These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32516450)

  • 1. Primary cutaneous melanoma risk stratification using a clinicopathologic and gene expression model: a pilot study.
    Arias-Mejias SM; Quattrocchi E; Tempel D; Luna-Vargas M; Chen J; Murphree DH; Gjorgova Gjeorgjievski S; Lehman JS; Bridges AG; Dwarkasing J; Meves A
    Int J Dermatol; 2020 Nov; 59(11):e431-e433. PubMed ID: 32516450
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive genetic profiles for regional lymph node metastasis in primary cutaneous melanoma: a case-matched pilot study.
    Nye A; Collins JD; Porter CL; Montes de Oca M; George K; Stafford CG; Schammel CMG; Horton S; Trocha SD
    Melanoma Res; 2018 Dec; 28(6):555-561. PubMed ID: 30179987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.
    Eggermont AMM; Bellomo D; Arias-Mejias SM; Quattrocchi E; Sominidi-Damodaran S; Bridges AG; Lehman JS; Hieken TJ; Jakub JW; Murphree DH; Pittelkow MR; Sluzevich JC; Cappel MA; Bagaria SP; Perniciaro C; Tjien-Fooh FJ; Rentroia-Pacheco B; Wever R; van Vliet MH; Dwarkasing J; Meves A
    Eur J Cancer; 2020 Nov; 140():11-18. PubMed ID: 33032086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.
    Kawada T
    Eur J Cancer; 2021 Nov; 157():516-517. PubMed ID: 34420836
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing Genetic Expression Profiles in Melanoma Prognosis.
    Farberg AS; Glazer AM; Winkelmann RR; Rigel DS
    Dermatol Clin; 2017 Oct; 35(4):545-550. PubMed ID: 28886811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAP1 expression in cutaneous melanoma: a pilot study.
    Murali R; Wilmott JS; Jakrot V; Al-Ahmadie HA; Wiesner T; McCarthy SW; Thompson JF; Scolyer RA
    Pathology; 2013 Oct; 45(6):606-9. PubMed ID: 24018818
    [No Abstract]   [Full Text] [Related]  

  • 7. The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil.
    Armengot-Carbó M; Nagore E; García-Casado Z; Botella-Estrada R
    J Am Acad Dermatol; 2018 May; 78(5):920-926.e4. PubMed ID: 29307636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
    Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
    J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma-A Clinical and an In Vitro Study.
    Kupczyk P; Simiczyjew A; Marczuk J; Dratkiewicz E; Beberok A; Rok J; Pieniazek M; Biecek P; Nevozhay D; Slowikowski B; Chodaczek G; Wrzesniok D; Nowak D; Donizy P
    Cells; 2021 Jan; 10(2):. PubMed ID: 33572647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of clinicopathologic variables and DNA ploidy in stage I cutaneous malignant melanoma.
    Tralongo V; Daniele E; Leonardi V; Rodolico V
    Oncol Rep; 1998; 5(5):1095-8. PubMed ID: 9683815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between BRAFV600E and NRASQ61R mutations and clinicopathologic characteristics, risk factors and clinical outcome of primary invasive cutaneous melanoma.
    Wu S; Kuo H; Li WQ; Canales AL; Han J; Qureshi AA
    Cancer Causes Control; 2014 Oct; 25(10):1379-86. PubMed ID: 25048604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of chromosomal aberrations and epigenetic changes in peripheral blood samples to identify patients with melanoma.
    Jakub JW; Grotz TE; Jordan P; Hunter E; Pittelkow M; Ramadass A; Akoulitchev A; Markovic S
    Melanoma Res; 2015 Oct; 25(5):406-11. PubMed ID: 26225582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification of cutaneous melanoma reveals carcinogen metabolism enrichment and immune inhibition in high-risk patients.
    Li X; Cai Y
    Aging (Albany NY); 2020 Aug; 12(16):16457-16475. PubMed ID: 32858528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers.
    Hyams DM; Cook RW; Buzaid AC
    J Surg Oncol; 2019 Jan; 119(2):175-186. PubMed ID: 30548543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic and Machine Learning Applications in Melanoma Risk Assessment and Prognosis: A Literature Review.
    Ma EZ; Hoegler KM; Zhou AE
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression Profiling in Cutaneous Melanoma: Caveats for Clinicians.
    Sominidi-Damodaran S; Pittelkow MR; Meves A
    Mayo Clin Proc; 2016 Aug; 91(8):1147-8. PubMed ID: 27492918
    [No Abstract]   [Full Text] [Related]  

  • 17. Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary.
    Johansson I; Tempel D; Dwarkasing JT; Rentroia-Pacheco B; Mattsson J; Ny L; Olofsson Bagge R
    Eur J Surg Oncol; 2022 Feb; 48(2):320-325. PubMed ID: 34794843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test.
    Ibrahim SF; Kasprzak JM; Hall MA; Fitzgerald AL; Siegel JJ; Kurley SJ; Covington KR; Goldberg MS; Farberg AS; Trotter SC; Reed K; Brodland DG; Koyfman SA; Somani AK; Arron ST; Wysong A
    Future Oncol; 2022 Mar; 18(7):833-847. PubMed ID: 34821148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining texture features of whole slide images improves prognostic prediction of recurrence-free survival for cutaneous melanoma patients.
    Peng Y; Chu Y; Chen Z; Zhou W; Wan S; Xiao Y; Zhang Y; Li J
    World J Surg Oncol; 2020 Jun; 18(1):130. PubMed ID: 32546168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model.
    Eggermont AMM; Bellomo D; Dwarkasing J; Meerstein-Kessel L; Meves A
    Eur J Cancer; 2021 Nov; 157():518-519. PubMed ID: 34565669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.